Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Translational Genetics and Genomics|January 17, 2024
Targeting KIR as a novel approach to improve CAR-NK cell functionLara V Graham, Jack G Fisher, Salim I Khakoo, et al.Vaccines|December 23, 2022
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against CancerJack G Fisher, Amber D P Doyle, Lara V Graham, et al.Exploration of Targeted Anti-Tumor Therapy|April 28, 2025
Modulation of anti-tumour immunity by XPO1 inhibitorsJack G Fisher, Laura G Bartlett, Trinayan Kashyap, et al.Frontiers in Oncology|December 20, 2021
Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-EJack G Fisher, Christopher J Walker, Amber Dp Doyle, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2022
KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer ActivityMatthew D Blunt, Andres Vallejo Pulido, Jack G Fisher, et al.Leukemia|August 1, 2023
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expressionJack G Fisher, Amber D P Doyle, Lara V Graham, et al.Frontiers in Oncology|September 17, 2024
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodiesLara V Graham, Jack G Fisher, Amber D P Doyle, et al.Immunotherapy Advances|September 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.Pageof 1